HAONasdaqServices-Advertising AgenciesFiscal year ends June 30

Haoxi Health Technology Ltd

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 30, 2026

$2.06−0.05 (-2.37%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Haoxi Health Technology Ltd income statement

AnnualQuarterlyTTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-06-30	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30
Revenue	55	33	49	28	16
Cost of Revenue	54	32	46	26	16
Gross Profit	0.63	0.93	2.75	2.06	0.65
Research & Development	0.10	0.08	0.08	0.06	0.10
General & Administrative	8.61	2.80	0.91	0.78	0.24
Operating Expenses	10	2.93	1.03	0.87	0.38
Operating Income	-9.66	-2.00	1.72	1.20	0.27
Interest Expense	0.05	0.05	0.04	0.02	–
Interest & Investment Income	0.22	0.36	0.08	–	–
Other Non-Operating Income	0.16	6.15	0.02	-0.01	-0.01
Asset Impairment Charges	1.50	–	–	–	–
Pretax Income	-9.50	4.15	1.74	1.19	0.26
Income Tax Expense	0.04	0.27	0.44	0.22	0.02
Net Income	-9.54	3.88	1.29	0.97	0.24
Net Income to Common	-9.54	3.88	1.29	0.97	–
EPS (Basic)(per share)	-386.40	4,251.81	2,701.53	2,228.07	640.25
EPS (Diluted)(per share)	-386.40	3,385.53	2,701.53	2,228.07	640.25
Shares Outstanding (Basic, Weighted)(shares)	0.02	0.00	0.00	0.00	0.00
Shares Outstanding (Diluted, Weighted)(shares)	0.02	0.00	0.00	0.00	0.00
EBITDA	-9.36	-1.71	1.73	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2026

Gross margin: 1.1%
Operating margin: -17.6%
Net margin: -17.4%
Return on equity, FY2026: -54.1%

Financial strength

Current ratio: 4.53
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 294.6%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –